ABVC BioPharma, Inc. Amortization of Debt Issuance Costs and Discounts
ABVC BioPharma, Inc. (ABVC) reported Amortization of Debt Issuance Costs and Discounts of $847.76 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2024-11-14
- ABVC BioPharma, Inc. amortization of debt issuance costs and discounts for the quarter ending 2024-09-30 was -$395.36K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2024-09-30 | -$395.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $847.76K 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $1.24M 10-Q · filed 2024-08-14 | |||
| 2023-12-31 | $1.44M 10-Q · filed 2024-11-14 |